All-oral shorter treatment regimens for multidrug- and rifampicin- resistant TB (MDR/RR-TB): A single arm prospective observational cohort study evaluating their effectiveness and safety for patients in Sierra Leone

Principal investigator

Location

Sierra Leone
Topic

Tuberculosis
Methodology

Cohort study: prospective
Reference

OCA021-14
Views

188
Downloaded

2

Purpose of study

To determine the effectiveness and safety of all-oral shorter MDR/RR-TB regimens of 9-12 month duration under operational research conditions in Sierra Leone.

Study status

Concept
Protocol & ERB
Implementation
Completion
Archived

Study timeline

Documents

01_ShoRRT_protocol_Sierra_Leone_v3.pdf 1.28 MB
MSF_ERB_approval_protocol_2066_26Mar21.pdf 98.2 KB

Publications

No publications recorded

Previous study

Next study